<code id='F88EE30B30'></code><style id='F88EE30B30'></style>
    • <acronym id='F88EE30B30'></acronym>
      <center id='F88EE30B30'><center id='F88EE30B30'><tfoot id='F88EE30B30'></tfoot></center><abbr id='F88EE30B30'><dir id='F88EE30B30'><tfoot id='F88EE30B30'></tfoot><noframes id='F88EE30B30'>

    • <optgroup id='F88EE30B30'><strike id='F88EE30B30'><sup id='F88EE30B30'></sup></strike><code id='F88EE30B30'></code></optgroup>
        1. <b id='F88EE30B30'><label id='F88EE30B30'><select id='F88EE30B30'><dt id='F88EE30B30'><span id='F88EE30B30'></span></dt></select></label></b><u id='F88EE30B30'></u>
          <i id='F88EE30B30'><strike id='F88EE30B30'><tt id='F88EE30B30'><pre id='F88EE30B30'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:611
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          TytoCare raises $49 million to build out AI
          TytoCare raises $49 million to build out AI

          AdobeYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Sign

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Dramatically reducing cancer deaths requires the PASTEUR Act

          ThesuperbugStaphylcocusepidermidisisshownonanagarplate.Morethan3millionAmericansdevelopadrug-resista